FDA Approves Dabigatran For Reduction of Risk and Recurrence of deep venous thrombosis and pulmonary embolism

Fetal_thrombotic_vasculopathy

The U.S. Food and Drug Administration (FDA) has approved the anticoagulant dabigatran (Pradaxa) “for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated,” according to a press release External Link from Boehringer Ingelheim Pharmaceuticals, Inc. Continue reading

Advertisements

Google embarks on smart contact lenses for diabetics – «Έξυπνους» φακούς επαφής για διαβητικούς αναπτύσσει η Google

GOOGLE SMART CONTACT LENSES

What if people with diabetes didn’t have to prick their fingers several times a day to conduct blood sugar tests — but instead could simply wear contacts?

Google has been working on smart contact lenses embedded with sensors “so small they look like bits of glitter” and an antenna “thinner than a human hair.” Continue reading